IL-15, rat recombinant protein
IL-15, MGC9721.
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P97604 |
---|---|
Calculated MW | 13.5 kDa |
Gene ID | 25670 |
---|---|
Gene Symbol | IL15 |
Other Names | IL-15, Interleukin 15 |
Gene Source | Rat |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥98% |
Assay2&Purity2 | HPLC; ≥98% |
Recombinant | Yes |
Results | <5 ng/ml |
Target/Specificity | IL-15 |
Application Notes | Reconstitute in 50 mM Tris, pH 8.5 to a concentration of 0.1-1.0 µg/ µl. The solution can then be diluted into other aqueous buffers |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and lyophilized with no additives |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
IL-15 stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activities primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues
References
Reinecker H.C.,et al.Gastroenterology 111:1706-1713(1996).
Park J.-H.,et al.Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.